[1] N BERNDT. The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane[J]. Cell Death and Differentiation, 2010, 17 11: 1795-1804. DOI:
10.1038/cdd.2010.63[2] PLAGEMANN P G. Transport, phosphorylation, and toxicity of a tricyclic nucleoside in cultured Novikoff rat hepatoma cells and other cell lines and relase of its monophosphate by the cells.[J]. JNCI Journal of the National Cancer Institute, 1976, 57 6: 1283-1295. DOI:
10.1093/jnci/57.6.1283[3] B C BEHRENS. Activity of tricyclic nucleoside 5’-phosphate in model systems of human ovarian cancer.[J]. Investigational New Drugs, 1986, 4 4: 295-304. DOI:
10.1007/bf00173502[4] ANTHONY R. PORCARI. Deoxy Sugar Analogues of Triciribine: Correlation of Antiviral and Antiproliferative Activity with Intracellular Phosphorylation[J]. Journal of Medicinal Chemistry, 2000, 43 12: 2438-2448. DOI:
10.1021/jm990205m 
